Pharmaceuticals News and Research

RSS

Medicare, Medicaid increasingly become hot topics in debt-ceiling talks

The future of these entitlement programs will be in play this week as negotiations continue, with both parties beginning to make concessions and hint that a deal could emerge.

20 Jun 2011

Panacea Global announces name change

Panacea Global Inc.,, a biopharmaceutical company specializing in blood (protein), serum and tissue tests to diagnose and monitor cancer, today announced the change of the Company's official trading symbol from MLXG to PANG.

20 Jun 2011

Pulmatrix introduces novel iSPERSE inhaled dry powder drug delivery platform

Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory diseases, today announced the launch of iSPERSE, the company's novel inhaled dry powder drug delivery platform.

20 Jun 2011

Spectrum announces various clinical studies on ZEVALIN at ICML 2011

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that various studies on ZEVALIN for Injection were presented at the 11th International Conference on Malignant Lymphoma (ICML), held June 15-18, 2011, in Lugano, Switzerland.

20 Jun 2011

Acura, Pfizer receive FDA approval for OXECTA Tablets to manage severe pain

Pfizer Inc. and Acura Pharmaceuticals Inc. announce the marketing approval from the U.S. Food and Drug Administration (FDA) of OXECTATM Tablets CII.

20 Jun 2011

Perceptive's Clinical Trial Management System now available as SaaS application

Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation, today announced that its Clinical Trial Management System is available as an on-demand, software-as-a-service (SaaS) application.

From Parexel 20 Jun 2011

Concert to advance CTP-499, C-21191 into Phase 2 trials for diabetic nephropathy and spasticity

Concert Pharmaceuticals, Inc. announced today the advancement of two programs from its DCE Platform. CTP-499 is progressing into Phase 2 clinical trials for diabetic nephropathy and C-21191 has been selected as a lead candidate for spasticity.

20 Jun 2011

Endo Pharmaceuticals, Jubilant achieve milestone in cancer drug development program

Jubilant Biosys Ltd., Bengaluru based subsidiary of Jubilant Life Sciences Ltd., and Endo Pharmaceuticals, of Chadds Ford, Pa, U.S.A., announced today that they have achieved a late stage discovery milestone in their joint program focused on cancer.

20 Jun 2011

Concert earns $4M milestone payment from GSK collaboration

Concert Pharmaceuticals, Inc. today announced that it has achieved a milestone in its strategic alliance with GlaxoSmithKline for its HIV protease inhibitor development program, resulting in a $4 million milestone payment to Concert.

20 Jun 2011

Alexion begins eculizumab clinical trial in Shiga-toxin producing E. coli hemolytic uremic syndrome

Alexion Pharmaceuticals, Inc. and Alexion Pharma International Sàrl (APIS), announced today that the Paul-Ehrlich-Institut, Germany's healthcare regulatory body for biological products, has authorized initiation of an open-label clinical trial to investigate eculizumab as a treatment for patients with Shiga-toxin producing E. coli hemolytic uremic syndrome, which has resulted from infections by Enterohemorrhagic Escherichia coli in an unusually wide outbreak in Germany that began in May.

20 Jun 2011

Chengdu Tianyin files renewal application for High Tech Enterprise Status

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced that the operating subsidiary of TPI, Chengdu Tianyin Pharmaceutical, has submitted the application for the renewal of its High Tech Enterprise Status at Chengdu, Sichuan Province of China.

20 Jun 2011

Pharma IQ publishes results of Industry-wide distribution survey

Pharma IQ has just published the results of an Industry-wide Pharmaceutical Distribution Survey, conducted recently among 3,000 pharmaceutical distribution specialist with over 83 % of those surveyed directly responsible for distribution at their respective companies.

20 Jun 2011

Scientists discover linchpin protein that drives mitochondria's calcium machinery

Mitochondria, those battery-pack organelles that fuel the energy of almost every living cell, have an insatiable appetite for calcium. Whether in a dish or a living organism, the mitochondria of most organisms eagerly absorb this chemical compound.

20 Jun 2011

Genomic study identifies MCU that regulates calcium transport into mitochondria

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at Massachusetts General Hospital (MGH), the Broad Institute, and the David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT), today announced new findings published in Nature.

20 Jun 2011

Risperidone recall by J&J

Ortho-McNeil-Janssen Pharmaceuticals Inc., a unit of Johnson & Johnson, recalled about 16,000 bottles of its Risperdal schizophrenia drug on reports of an uncharacteristic odor. The recall affects one lot that was shipped between Aug. 27, 2010, and Feb. 15, 2011.

19 Jun 2011

Watson Pharmaceuticals confirms SEASONIQUE patent challenge

Watson Pharmaceuticals, Inc., a leading integrated global pharmaceutical company, today confirmed that the United States District Court for the District of Nevada denied Duramed Pharmaceuticals, Inc.'s request for a preliminary injunction and request for a temporary restraining order preventing Watson's launch of generic SEASONIQUE and ethinyl estradiol.

18 Jun 2011

Study evaluates impact of medication adherence, comorbidity on workforce productivity

A new study suggests that while medication adherence is a critical element in reducing the impact of illness, employers should view it as just one of multiple components that are needed in strategic employee disease-management initiatives.

18 Jun 2011

$Future burden of fractures could be avoided with increased treatment uptake: Study$

Future burden of fractures could be avoided with increased treatment uptake: Study

It pays to prevent fractures. That's one of the main findings of a landmark report 'Osteoporosis - Burden, Healthcare provision and Opportunities in the European Union' newly published in the journal Archives of Osteoporosis.

18 Jun 2011

Dems introduce bills to push for Medicare negotiated drug pricing

Congressional Democrats have introduced legislation to let Medicare negotiate prescription drug prices - a move that could result in significant savings, the bill supporters say. They are urging that their measure be included in the effort to raise the debt ceiling.

18 Jun 2011

Study shows increase in emergency department visits for drug-related suicide attempts among men

A new national study shows that from 2005 to 2009 there was a 55 percent increase in emergency department visits for drug related suicide attempts by men aged 21 to 34 -- from 19,024 visits in 2005 to 29,407 visits in 2009. In 2009, there were a total of 77,971 emergency department visits for drug-related suicide attempts among males of all ages.

18 Jun 2011